Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: 64 - Caught on Camera

Pfizer-BioNTech Seek US Approval of Second Covid Booster for 65+

Pfizer and BioNTech announced Tuesday they had formally asked the United States drug regulator for emergency approval of a second booster shot of their Covid vaccine for people aged 65 and older. The companies said in a press statement that their request is based off two Israeli studies that show…

Asharq Al-Awsat

Pfizer asks FDA to clear another booster for older adults

Pfizer Inc. said it has asked U.S. regulators for clearance of an additional COVID-19 booster shot for seniors, in a bid to protect vulnerable adults as immunity provided by the first three doses wanes.

Tribune News Service

The Loop: Another Pfizer booster on table in US, hospital hostages in beseiged Mariupol, and a Grammys showstopper

Here's your TL;DR for this morning's news.

ABC News

From analysis to the latest developments in health,
read the most diverse news in one place.

AP source: Pfizer seeking OK for 4th COVID dose for seniors

Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors

The Independent UK

Pfizer and BioNTech plan to seek authorization for second COVID booster for people 65 and up

The move is an attempt to bolster waning immunity that occurs several months after a first booster shot.

Axios

News briefs

Fourth COVID shot will be ‘necessary,’ says Pfizer CEO

Tribune News Service

Pfizer halts trials in Russia but will continue to supply drugs

Pfizer Inc. said it would no longer start new clinical trials in Russia and that it would donate all profits from its subsidiary in the country to Ukraine relief causes.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Pfizer CEO says fourth vaccine dose will be needed

CDC only authorised third jab for most adults in the fall

The Independent UK

Pfizer To Stop New Clinical Trials In Russia: Reuters

Reuters reported that Pfizer Inc (NYSE: PFE) said it wo

Benzinga

Here's Why Pfizer And Novavax Shares Are Rising On Monday

Pfizer Inc. (NYSE: PFE) and Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 4.3% at $52.42 and 9.6% at $80.05 respectively. Strength is possibly due to a spike in COVID-19 cases in China, which could lift vaccine sector sentiment.

Benzinga

Pfizer-BioNTech's COVID-19 Shot Moderately Effective Against Omicron In Kids Aged 5 to 15, CDC Study Shows

The Pfizer Inc (NYSE: PFE) - BioNTech SE (NASDAQ: BNTX) vaccine is only moderately effective against the omicron variant when tested in children ages 5 to 15.

Benzinga

Fourth COVID shot will be ‘necessary,’ says Pfizer CEO

COVID-19 shots could soon become an annual item on your to-do list.

Tribune News Service

Pfizer’s Covid-19 Drug Arrives in Hong Kong, City’s Leader Says

The first batch of 75 Chinese mainland medical personnel has also arrived in Hong Kong to boost the city’s capacity to treat severe cases amid the worst local outbreak

Caixin Global

Pfizer, Bayer to maintain drug supply to Russia

Pfizer Inc and Bayer said on Monday they would maintain humanitarian supply of medicines to Russia, but would pull back from other non-essential spending in the country.

Reuters

Get all your
news in one place.

100's of premium titles.
One news app.

Wales Online

Pfizer vaccine reduces Covid infections in children, research finds

It also reduces the severity for those that do catch the virus

The Independent UK

Covid-19 vaccine ‘reduces infections in children’ – study

It is expected that five to 11-year-olds in England will be called forward for vaccines in April.

The Conversation

Two years into the pandemic, unequal access to COVID-19 treatments threatens the global recovery

It’s now two years since the World Health Organization began calling the COVID-19 outbreak a pandemic.

Caixin Global

Weekly Must-Read: China Meheco Confirms Pfizer Talks on Selling Paxlovid in China

State-owned drugmaker’s shares surge by 10% limit on four straight days in Shanghai, though its role may be limited to distribution logistics

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Which companies aren’t exiting Russia? Big pharma

Even as the war in Ukraine has prompted an exodus of international companies — from fast-food chains and oil producers to luxury retailers — from Russia, U.S. and global drug companies said they would continue manufacturing and selling their products there.

ABC News

George Christensen says 'elites' have suddenly started hiding vaccinated death statistics. Here's why that's wrong

Coalition backbencher George Christensen took to Facebook this week to claim the government has suddenly stopped reporting vaccinated death statistics. Is that correct?

Al Jazeera

Africa CDC signs MOU with Pfizer to supply COVID-19 pills

The confirmation from Africa’s top public health agency comes within days of Modena and J&J announcing deals in Africa.

The Independent UK

Ukraine publishes list of 50 global brands that are continuing to operate in Russia

Burger King suspends operations in Russia after being named on list alongside Pfizer, Johnson and Johnson and Samsung Electronics

Tribune News Service

Vacunados con J&J, reforzados con ARNm, y pensando en la tercera dosis

Sí, todos estamos agotados por la pandemia de covid. Desconcertados por los constantes cambios en la ciencia y en las directrices. Preocupados por la sucesión de nuevas y temibles variantes, cada una con su propio nombre, como los huracanes.

Tribune News Service

Pfizer studying COVID pill Paxlovid in children age 6 and older

Pfizer Inc. said it launched a study of its oral Covid-19 treatment among children age 6 and up who have been infected by the virus and are at risk of progressing to severe disease.

Benzinga

Pfizer's Paxlovid Becomes First Oral COVID-19 Therapy To Be Evaluated In Pediatric Clinical Study

Pfizer Inc (NYSE: PFE) has initiated a Phase 2/3 EPIC-PEDS trial to evaluate Paxlovid (nirmatrelvir and ritonavir tablets)

1 … 63 64 65 66

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.